Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $88.01 ($257K) on 2015-07-01, disclosed to the SEC on 2015-07-02.
Scheduled sale ($257k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.19 | 2,000 | $170K | 66.3% |
| 2 | $86.56 | 900 | $78K | 30.3% |
| 3 | $88.01 | 100 | $9K | 3.4% |
| Total | $85.69 avg | 3,000 | $257K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |